1.
Infect Control Hosp Epidemiol
; 45(5): 667-669, 2024 May.
Artículo
en Inglés
| MEDLINE
| ID: mdl-38151334
RESUMEN
We evaluated diagnostic test and antibiotic utilization among 252 patients from 11 US hospitals who were evaluated for coronavirus disease 2019 (COVID-19) pneumonia during the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) omicron variant pandemic wave. In our cohort, antibiotic use remained high (62%) among SARS-CoV-2-positive patients and even higher among those who underwent procalcitonin testing (68%).